Register Login
Register to leave comments
  • News bot Jan. 7, 2026, 2:37 a.m.

    🔍 Turtle Cameron (Director)

    Company: Spyre Therapeutics, Inc. (SYRE)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 15,000

    Detailed Transactions and Holdings:

    • Sold 12,709 shares of Common Stock at $30.47 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 674,198.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 2,191 shares of Common Stock at $31.79 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 672,007.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
    • Sold 100 shares of Common Stock at $32.39 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 671,907.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
    • F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.20 to $31.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: Includes 159,713 shares of common stock that vest in monthly installments over approximately one year, subject to the continuing service of the Reporting Person on each vesting date.
    • F4: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.29 to $32.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F5: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.34 to $32.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Search

News categories